The process of setting screening perform.ance targets requires an estim.ate of what the incidence of breast cancer would have been in the population invited for screening if there had not been a screening program.m.e. Before the introduction of the National Health Service breast screening program.m.e in 1988 the incidence ofbreast cancer was already increasing in the population targeted for screening. To establish the incidence before screening the m.ost recent com.plete data from. all the regional cancer registries were collated. An age-period m.odel was constructed to predict what these incidence rates m.ight now have been if the screening program.m.e had not been introduced. The m.odel predicted that if prescreening trends continued (between 1987 and 1995) underlying incidence over this period would increase by 2.3 per 10000 in wom.en aged 50-54, 2.6 per 10000 in wom.en aged 55-59, and 2.9 per 10000 in wom.en aged 60-64. If the prescreening trends have continued then the use of a universal rate, applied across all calendar years and age groups, would seem. to be inappropriate when setting targets. Age (2)* Age (3) Calendar year Residual *Age strata: 50-54 years, 55-59, and 60--{j4.
The National Health Service breast screening programme (NHSBSP) started in 1988 and screens women aged 50-64 at intervals of three years. It will be many years before a reduction in mortality can be shown and in the interim it is necessary to have surrogate indicators of screening performance -for example, the cancer detection rate in the screened population and the occurrence of interval cancers."? The process of setting screening performance targets requires an estimate of what the incidence of breast cancer would have been in the population invited for screening if there had not been a screening programme. Initially, the NHSBSP targets were based on the incidence of breast cancer in women aged 50-64 in England and Wales before the introduction of screening. The continuing use of a fixed historical incidence rate presents certain difficulties because the incidence of breast cancer was already increasing before the introduction of the NHSBSP (Quinn MJ, Allen EJ, unpublished data)" If the underlying incidence of breast cancer is now higher in the age group screened then targets will need to be adjusted. In this paper we examine how rates were increasing before the introduction of screening and use an age-period model to estimate what the incidence might have been between 1988 and 1995 if there had not been a screening programme.
Methods
Details of all new cases of invasive breast cancer (ICD-9 174, n = 92916) diagnosed in women between the ages of 50 and 64 between 1 January 1980 and 31 December 1992 were obtained directly from all 11 English regional cancer registries and were collated by year and five-year age band. Annual population estimates were also supplied by the cancer registries and were used in the calculation of age specific rates in five-year bands. Directly standardised incidence rates for the combined registries were calculated for invasive breast cancer, with the 1980 England and Wales population as the reference population.
STATISTICAL MODELLING
Age specific rates for the combined data were fitted by Poisson regression models' using the GLIM computer package." The rate was fitted as the dependent variable, with the population as the weighting factor, and declaring Poisson error and logarithmic link functions. The effect of an individual variable in a model was assessed by examination of the change in scaled deviance, which approximates to a X: variable with the appropriate degrees of freedom. Trend over time was tested by referring~/standard error in~to tables of the normal distribution,~being the regression coefficient of the variable for calendar year.
The model used calendar year and age as the main effects. The addition of an age-year interaction term improved the model fit and resulted in an adequate model. However, on extrapolation to 1995 the model predicted that the rate for the age group 50-54 would be higher than that for age group 55-59. On inspection of the residuals, three outliers were found, of which, one in 1980 (55-59) and one in 1987 (60-64) account for most of the interaction effect. It was likely that they represented random fluctuations occurring at the limits of the data. The model was, therefore, rescaled in terms of the mean residual variance and refitted. The effect of this process left the 
Results
During the period before screening the directly standardised combined incidence of invasive breast cancer in women aged 50-64 increased from 17.45 in 1980 to 19.58 per 10000 in 1987; a modest average annual increase of 0.3 per 10000 women. Between 1987 and 1992, during the first round of screening, the average annual increase was 1.3 per 10 000. Inspection of the age specific regression model showed that after controlling for age, calendar year made a significant contribution to the model. The regression coefficient for trend over calendar year of 0.0158 represents a year on year increase in the incidence of about 1.6%. Extrapolation from this model produced the estimates of incidence for 1987-95 that are shown in table 2, together with 95% precision intervals. The corresponding observed rates of invasive breast cancer for 1987 and 1992 are given for comparison. Population incidence rates for 1993-95 are not yet available.
Between the years 1987 and 1995 the projected rate for age group 50-54 ranged from 16.7 to 18.9 per 10000; from 19.3 to 21.9 per 10000 for the 55-59 age group, and from 21.7 to 24.7 per 10 000 for those aged 60-64. Figure 1 shows the observed incidence of breast cancer in women aged 50-54 between 1980 and 1992 and the incidence derived from the age specific regression model with 95% precision intervals. It can be seen that the observed incidence of breast cancer increases more sharply after the introduction of screening, but as the rates had been increasing before 1988 only part of the rise after 1988 should be attributed to screening.
Discussion
The value of the results presented here rests on the quality of the data on which they are based. Published cancer incidence data for the early 1980s are known to be incomplete, for various reasons, though not necessarily unrepresentative." • Registry data sets are not static but are continually updated as new information is acquired and therefore in order to ensure the maximum accuracy for our estimates we collaborated with other regional cancer registries in England to bring together the most up to date information available for the relevant years. Data were elicited in 1993 initially for 1980-92 registrations and when updates of the data for the years 1990-92 were submitted by the registries to the Office of Population Censuses and Surveys in 1995 this more recent information was made available to us and used in the final analyses.
The age-period model presented reflects the upward trend of age adjusted rates reported from many countries. 1 0- 12 Several studies sug- Estimated rau (/1rt) parameter estimates unchanged but increased their standard errors. Prediction intervals were derived for individual rates from the variance of the linear predictor multiplied by the mean residual variance'; the former allows for increasing uncertainty when extrapolating at a distance from the mean of the available data and the latter for random variation unrelated to the explanatory variables. Summary statistics of 2.688 (0.0188) 0.144 (0.0172) 0.263 (0.0167) 0.0158 (0.00295)
Start of screening programme 1988
Time from first screen (months) total number of women screened.' This method, however, does not allow for withdrawals from the cohort in each of the years of follow up. To allow for withdrawals we now calculate "women-years" at risk in each year by calculating entrants to the next year of observation as N ( 2 ) = N CI ) expected deaths (1) -observed cancers(1)' The expected number of cancers can now be calculatedfirstly, by using the pre screening rate, and then, by using the rates from the model. The first approach multiplies the number of "womenyears" at risk by 18.3/10000 and, the second, multiplies the number of "women-years" at risk in each five-year age group and each yearly interval by the appropriate age and calendar year specific rates, as predicted by the model. Table 3 compares the results of these two approaches, where it can be seen that the number of women at risk in the cohort decreases because of withdrawals: those dying from other causes or those developing breast cancer and at the same time the number of observed interval cancers increases over time. The effect of using the rates from the model is to increase the expected numbers of cancers in each year, with the effect of reducing the interval cancer rate expressed as a proportion of background incidence -(observed/expected number) x 100. Therefore, the use of this method resulted in more conservative estimates of interval cancer rates. Clearly, however, the increase in the background incidence of breast cancer noted before the screening programme began is an incomplete explanation for the high rates of interval cancer observed. gest that the rise in incidence is more appropriately explained by cohort than by calendar period effects.' [10] [11] [12] [13] The validity of the extrapolation would be in doubt if strong cohort effects were operating to reduce the rates. The data available to us (a short period and restricted age groups) are insufficient to demonstrate cohort effects. Analyses carried out on data collected for much longer periods, by individual United Kingdom registries, have not shown cohort effects. 13 The estimates given here should, therefore, be accepted with this reservation together with the statistical uncertainties that arise when extrapolating beyond the range of the available data. The latter point has been dealt with partially by the method used to calculate the prediction intervals.
Nevertheless, our results do give support to previous reports of an increasing incidence of breast cancer and suggest that the increase was operating before the start of the national screening programme. Whether the increase would have continued in this population in the absence of screening is now impossible to confirm because more than 70% of the target group have been screened. Our model predicts that if prescreening trends continued (between 1987 and 1995) underlying incidence over this period would increase by 2.3 per 10000 in women aged 50-54, 2.6 per 10000 in women aged 55-59, and 2.9 per 10000 in women aged 60-64. If the prescreening trends have continued then the use of a universal rate, applied across all calendar years and age groups, would appear to be inappropriate when setting targets.
AN ILLUSTRATIVE EXAMPLE
We now test the effect of using incidence rates from the model on the interpretation of interval cancer rates. An interval cancer occurs when a woman who has had a negative screening test presents with breast cancer before her next screening test is due, and unexpectedly high numbers of these have been reported from the NHSBSP. Interval cancer rates are usually expressed as a proportion of the background incidence -that is, the expected incidence of breast cancer in the absence of screening. In a randomised controlled trial the experience of the control group provides an estimate of the background incidence, but for the NHSBSP this option is not available as all eligible women are invited. Instead, general population estimates of incidence for the age range 50-64 in the year preceding the introduction of the programme have been used as a measure of background incidence.
To test the effect of the age and calendar year specific estimates from the model on the incidence of interval cancers as a proportion of background incidence we use the interval cancer rates seen in two annual cohorts from three screening centres. Previously, to derive the expected number of cancers in each year following a negative screen we applied the prescreening regional incidence rate of breast cancer in women aged 50-64, 18.3/10000, to the
